Navigation Links
Outcomes Improve for Non-Hodgkin Lymphoma Patients
Date:3/11/2008

erm survival in patients with non-Hodgkin lymphoma obtained by the period analysis for the 2002 to 2004 period are much higher than previously available survival estimates, which mostly pertain to patients diagnosed in the 1990s," the researchers concluded. "Timely disclosure of the improvements in survival achieved in patients, clinicians, researchers and the public is essential."

The study was published in the March 10 issue of the Archives of Internal Medicine.

More information

The American Cancer Society has more about non-Hodgkin lymphoma.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, March 10, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Comparison of obstetric outcomes between on-call and patients own obstetricians
2. Continued Statin Use Boosts Post-Stroke Outcomes
3. QI projects may -- or may not -- improve patient safety and outcomes
4. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
5. Bypass Off-Pump Boosts Womens Outcomes
6. Mayo Clinic study indicates medication for ADHD may help student outcomes
7. Experts Compare Colon Cancer Treatment Outcomes
8. Gene Chip Data Can Boost Cancer Outcomes
9. Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes
10. Studies suggest key correlation between lung cancer subtype and treatment outcomes
11. Meta-Analysis of Blood Phe Levels and Clinical Outcomes in PKU Published
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Outcomes Improve for Non-Hodgkin Lymphoma Patients
Outcomes Improve for Non-Hodgkin Lymphoma Patients
(Date:1/8/2009)...8 /PRNewswire-FirstCall/ - Med-Emerg International...eading providers of health services, is pleased to...ur of the previously announced plan of arrangement...AIM") at a special meeting of MedEmerg,s sharehold... votes cast at the meeting were in favour of the A...
(Date:1/8/2009)...., Jan. 8 Today, the Na...ong with several national leadership organizations...ples of hospice care and protection of the Medicar...ther in sharing this unified message about end-of-...and Palliative Medicine, Hospice and Palliative Nu...
(Date:1/8/2009)...embly Member Tom Torlakson Introduces AB 89 , ,.../ -- Today, Lung Cancer Alliance-California (LCA...son (D-11th District) for his continued leadership...lung cancer research. For the third consecutive y...rch is being considered in the California Legislat...
(Date:1/8/2009)...ered bad cholesterol more effectively than Zocor ,...After nearly a year of review, U.S. health officia... use of the controversial cholesterol-lowering dru...ion said there was no significant difference in ca...orin and patients taking the drug Zocor. , But,...
Breaking Medicine News(10 mins):Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:FDA Backs Cholesterol Drug Vytorin 2
...ording to an official report, 36 patients died and...e to the mistakes in the drug prescribed and given... Above 41,000 'medication errors' were recorded i... the period of July 2005 to July 2006. This inform...
... doctors in UK have warned that with the rising po...of the general health could be threatened.// An a...e Lancet by Scientists from the Sunderland Eye Inf...icle in the online edition of the Lancet, to highl...
...mertime is for hiking and camping, but it brings w...potted fever. In order to prevent such illnesses, ...tioxidants like alpha-lipoic acid and green tea an...tion by rickettsia bacteria. The National Institu...
... BMA today (Thursday 10 August, 2006) questions th...the funding available for health research which, i...fferent fronts. Under HM Treasury plans, a new sin...be created for health research, which is currently...
Other Medicine News:Health News:Online Drugs Could Prove Hazardous To health Warn Doctors in UK 2Health News:Antioxidants Could Halt Rocky Mountain Spotted Fever 2Health News:NHS research under pressure, and could face ?300 million cut, BMA warn 2
(Date:1/6/2009)...ts from prior U.S., U.K. and China Trials , , S...Inc. (VTI), a development stage company targeting ...has begun for a randomized, controlled, multi-cent...racorporeal Liver Assist Device (ELAD) as a treatm...der three protocols. The study is open for enrollm...
(Date:1/6/2009)...e/ -- Cequent Pharmaceuticals, a pioneer in the de...treatments to prevent and treat human disease, ann...uccessful toxicology study of its candidate CEQ501...eting the primary oncogene (beta-catenin, CTNNB1) ... inherited gastrointestinal disease that causes hu...
(Date:1/5/2009)...swire/ -- Women undergoing in vitro,fertilization...port early,pregnancy, but the intramuscular injec...inful for patients. Formulations of progesterone ...ous injection or vaginal suppository may offer,si... With patient well-being a constant focus, Fert...
(Date:12/27/2008)...ewswire/ -- According to the latest,science, resv...est doses of,resveratrol plus an array of antioxi...asses of aged, red wine, rather than resveratrol a...i-bin/prnh/20080603/LATU039 ) , The most r...s to prolong,the life of laboratory mice. In fac...
Breaking Medicine Technology:ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3IMTEC Introduces the SPRITE CT System 21584 1IMTEC Introduces the SPRITE CT System 21584 2HMS Holdings Corp to Present at Jefferies 2nd Annual Healthcare Conference 21582 1COSE Introduces Health Incentives Wellness Programs for Medium Size Businesses 21580 1COSE Introduces Health Incentives Wellness Programs for Medium Size Businesses 21580 2Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 1Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 2Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 3Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 4Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 5
...gression-free survival in,the SPARC Phase 3 trial ...isk of disease progression for patients receiving,...e use,geographies, as well as presence or absence...tCall/ -- Pharmion,Corporation and GPC Biotech AG ...a from the double-blind, randomized satraplatin Ph...
...ts EORTC 40983 (EPOC),Intergroup Study Results, CH...ults of the,randomized phase III EORTC 40983 Inter...rst time that peri-operative (pre and post,surgery...combination with a standard chemotherapy regimen f...V)) given to patients with,resectable liver metast...
Other Medicine Technology:Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 2The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 3The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 4The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 5The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 6The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 7The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 8The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 9
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: